Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)

Clinical trial NCT04004793 · COMPLETED

Trial details

NCT number: NCT04004793
Sponsor: Shanghai Zhongshan Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2020-06-12
Primary completion: 2023-01-31
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.